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1 GENERAL PART 
1.1 ANALYTICAL CHALLENGES IN FORENSIC TOXICOLOGY 
1.1.1 Introduction 
A forensic toxicologist has to deal with different questions every day. Post-mortem 
cases – was there a poisoning? Driving under the influence of drugs (DUID) cases – 
which drug was involved? Driving ability assessments – is the suspect abstinent? 
Drug facilitated crimes – was there an influence by the time of the offense? Seizures 
of drugs – what kind of drugs are involved? Are there (toxic) cutting substances? 
Finding every important detail, however small it might be, is a great challenge in 
forensic toxicology. This might be a small amount of a toxic compound or a new 
substance. Sometimes there are only traces, but following these traces might lead to 
the answer of the case. Being up to date is important, because constantly new drugs 
are conquering the market [1,2]. These new drugs have to be covered, making the 
development of new analytical methods an indispensable task in forensic toxicology. 
These analytical methods can also be used in clinical toxicology and therapeutic drug 
monitoring (TDM). Therefore, cooperation of experts in those fields might be valuable 
for both sides. 
 
1.1.2 Drug classes 
In the presented work, drugs of abuse with a special focus on new psychoactive 
substances as well as medicaments such as benzodiazepines including the so-called 
“z-drugs” and phosphodiesterase type 5 enzyme inhibitors such as the “Viagra” 
ingredient sildenafil have been chosen as showcase analytes. The methods that 
have been developed for their determination were used to answer actual forensic 
problems. 
 
1.1.2.1 Drugs of abuse 
Drugs of abuse represent an important class in forensic toxicology as their 
possession, their consumption and dealing are strictly forbidden. For roadside testing 
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in driving under the influence of drugs cases, oral fluid and urine roadside 
immunoassay tests are widely used. Positive tests must be confirmed in blood by a 
second independent method (most often mass spectrometric methods after 
chromatographic separation). Cannabinoids, opioids, cocaine, amphetamines and 
designer drugs such as methylenedioxymethylamphetamine (MDMA) are the main 
categories. Their determination is included in the daily routine in a forensic 
laboratory. There are immunoassays (IA) for screening and gas chromatography 
(GC) or liquid chromatography (LC) mass spectrometry (MS) methods for quantitative 
analysis [3,4,5,6]. Past consumption can be determined by hair analysis, which can also 
prove abstinence in driving ability assessments.  
The class of drugs of abuse is growing constantly. There are different groups of new 
psychoactive substances that are coming up to be used in clubs or at music events. 
They are sold via internet and disguised as ‘bath salts’, ‘research chemical powders’ 
or ‘plant food’. One group is formed for example of the piperazines, such as 
benzylpiperazine (BZP), trifluoromethylphenylpiperazine (TFMPP) and meta-
chlorophenylpiperazine (mCPP). Another group includes cathinone and the other 
beta-keto-amphetamines such as methylone, butylone, ethylone, methcathinone and 
mephedrone (4-MMC) (for the structures of the typical piperazine BZP and 4-MMC, 
as representative of the cathinone derivatives, see Figure 1). The pyrrolidinophenone 
methylenedioxypyrovalerone (MDPV) is also a derivative of cathinone. Information 
about the pharmacology and toxicological effects are rare; some studies, mainly case 
reports, have been published recently [7,8,9,10,11,12,13,14]. Additionally, little is known 
about the prevalence of these psychoactive substances. One reason is that they do 
not interact with the common immunoassays, consequently these screening tests are 
blind for these substances. Besides, the portfolios of the analyzing laboratories often 
do not contain new psychoactive substances. This results in a high number of 
unreported cases. 
Another problem with these new psychoactive substances is that they are often not 
listed in the narcotic act. “Nulla poena sine lege” – if there is no law, one can’t be 
punished. Therefore, it is important to keep an eye on the drug market and identify 
new psychoactive substances in order to be able to schedule them under controlled 
substances act. Consequently, development of new analytical methods for their 
determination is one of the pressing tasks of a forensic toxicologist. 
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Figure 1: Structures of the piperazine BZP (A) and cathinone derivative 4-MMC (B). 
 
1.1.2.2 Medicaments 
Medicaments are a big heterogenic group and some have a high influence, e.g. on 
driving ability, either alone or in combination with alcohol. These are for example 
sedatives, hypnotics, neuroleptics or antidepressants. Substances acting on the 
benzodiazepine receptor system are often prescribed for therapy of anxiety and 
sleeping disorders or epilepsy and there is a high potential for abuse. The so-called 
‘z-drugs’, namely zolpidem, zopiclone and zaleplon, have no structural relation to the 
benzodiazepines (examples given in Figure 2), but they are agonists of the 
benzodiazepine-1 (omega-1) receptor. The sedating effects of both groups, 
benzodiazepine and z-drugs as well as their side effects, such as lack of 
concentration, can reduce the ability to drive a car [15,16,17]. Unfortunately, they also 
found their way into the category of rape drugs and are connected to drug facilitated 
crimes [18]. Acute influence of drugs and medicaments can be determined in blood 
and in urine; past consumption can be shown using hair analysis. Therapeutic drug 
monitoring in blood(plasma) is widely used to check the compliance of a patient and 
to adjust dosage.  
A group of medicaments of both clinical and forensic interest are inhibitors of the 
human cGMP-specific phosphodiesterase type 5 enzyme (PDE 5), such as sildenafil 
(Viagra®, Revatio®), vardenafil (Levitra®) and tadalafil (Cialis®, Adcirca®) (see 
Figure 3). As treatment for erectile dysfunction [19], there might be a connection to 
‘mors in actu’ cases (death during sexual intercourse). Being a so-called life-style 
medicament, the risk of fake products on the black market is high. Sildenafil and 
tadalafil are also licensed for treatment of pulmonary arterial hypertension [20], 
because PDE 5 is also present in lung blood vessels and therefore its inhibition leads 
to selective pulmonary vasodilatation.  
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Figure 2: Structures of the benzodiazepines diazepam (A) and flunitrazepam (B) and of the z-drugs 
zolpidem (C) and zopiclone (D) 
 
 
Figure 3: Structures of the PDE5 inhibitors sildenafil (A), vardenafil (B) and tadalafil (C)  
 
1.1.3 Biological matrices 
In the presented work, blood as the most common biological matrix in forensic 
toxicology as well as hair as the most common alternative matrix have been used to 
answer specific forensic questions. Some peculiarities of the different biological 
matrices in forensic toxicology are discussed in this chapter. 
In forensic toxicology determination of xenobiotics in different biological matrices is 
necessary. The most common are blood (plasma, serum), urine and nowadays also 
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alternative matrices such as hair and oral fluid. Additionally, gastric content and 
tissue samples (muscle, liver, kidney, brain) have to be worked up, especially in post 
mortem cases when blood or urine are no longer available. Sometimes even 
perinatal matrices, such as meconium, have to be used to assess drug intake during 
pregnancy.  
The best correlation between the drug concentration and the resulting pharmacologic 
effects is given in blood (plasma, serum), which is therefore useful for interpretation 
e.g. for assessment of impairment [5]. Drawbacks are often the limited volumes of 
blood for analysis and that the collection of blood has to be done by a professional.  
Urine has a great advantage for that it can be obtained non-invasively and high 
volumes are often available [5]. Concentrations are higher in urine because of 
physiological concentration in the kidneys. Unfortunately, not in all cases parent 
compounds can be found in urine, because they have been metabolized. In order to 
analyze the metabolites of a specific compound, the metabolic pathways must be 
either known or established to assure which structure is of interest. Additionally, 
metabolites are partly excreted in conjugated form. These conjugates must either be 
cleaved or included into the analytical procedure [21].  
In hair drugs are incorporated and stored for a long time [22]. Hair is like a recorder, it 
plots the consumption behavior depending on hair length. Therefore, retrospective 
investigation over months to years is possible. Assessment of acute impairment is 
however not possible. A great advantage compared to blood and urine is that hair 
can be stored at ambient temperature, so no space in freezing compartments is 
needed avoiding freeze-thaw stability problems. If no head hair is available, the use 
of body hair, e.g. chest hair, is also possible. A weakness of hair as analytical matrix 
is the risk of external contamination with drug powder or smoke. To differentiate 
between actual ingestion of a substance and external contamination, analysis of 
metabolites might be necessary. The Society of Hair Testing (SoHT) gives further 
recommendations [23].  
Oral fluid can be obtained non-invasively like urine, but much more easily and less 
intimate. These advantages make oral fluid a valuable matrix for roadside drug 
testing. Oral fluid testing is also used in controlled trials in other fields, e.g. smoking 
cessation [24].  
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1.1.4 Analytical toxicology 
The presented work focuses on the use of modern liquid chromatography tandem 
mass spectrometry (LC-MS/MS) technology for answering forensic questions. 
Besides the use of modern instruments, sample preparation, identification criteria and 
validation must be considered. 
 
1.1.4.1 Sample preparation 
Before these different matrices can undergo a toxicological analysis, a good sample 
preparation is necessary. The most common ones are liquid-liquid extraction (LLE), 
solid-phase extraction (SPE) and protein precipitation. The aim of a sample 
preparation is a high concentration of analytes of interest and a loss of everything 
that might interfere [25]. This is of special importance when using LC-MS/MS because 
this technique is prone to matrix effects especially when applying electrospray 
ionization (ESI) [26]. Matrix effects can cause both higher signals of the analyte (ion 
enhancement) and lower signals (ion suppression). Therefore a good sample clean-
up is mandatory.  
For hair samples, the sample preparation is more complicated. First, decontamination 
is necessary to get rid of cosmetic treatments and external contamination. Second, 
the incorporated substances must be extracted. This can be done in different ways, 
e.g. extraction with methanol, aqueous acids or buffer solutions; digestions with 
enzymes or sodium hydroxide [22]. After the extraction or digestion, a LLE or SPE is 
recommended.  
Another important point in sample preparations is the use of an internal standard. For 
LC-MS/MS procedures the use of stable-isotope-labeled (SIL) internal standards, e.g. 
deuterium labeled compounds, is recommended because they can compensate for 
analytical problems (e.g. matrix effects, recovery) [27].  
 
1.1.4.2 Analytical techniques 
Analytical procedures in forensic toxicology comprise identification steps followed by 
(validated) quantification. At last, interpretation of the results by the forensic 
toxicologist is needed and an expert report is given. Routinely, samples are 
prescreened using immunoassays [6]. These results must be confirmed by another 
method. In the last decades, GC-MS was the gold standard for that purpose [28]. GC-
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MS shows good sensitivity and gives spectral information for identifying analytes [28]. 
Many GC-MS methods for the determination of drugs of abuse in blood have been 
published [6]. 
In recent years, starting in the 1990s, the LC-MS(/MS) technique is establishing itself 
in the field of analytical toxicology [29]. Especially for analytes which do not perform 
good with GC-MS, such as non-volatile, hydrophilic and thermo labile analytes [5]. 
Peters gives an overview over the recent developments and published methods 
using LC-MS(/MS) [5]. When using a tandem mass spectrometer quantification is 
done best employing the multi reaction monitoring (MRM) mode. The first quadrupole 
monitors the mass of a given compound and the third quadrupole scans for fragment 
ions that had been selected in previous experiments. It provides a high selectivity 
and sensitivity, because only the analytes of interest are scanned. The use of internal 
standards is recommended as given above (see 1.1.4.1). 
Nowadays, new analytical methods should be fully validated, at least if the analytes 
are to be determined on a regular basis. Full validation for a single analyte which 
might appear once a year or even less is not necessary, but its detection is 
indispensable for an unknown screening in clinical and forensic toxicology. An 
overview over the recent published approaches for toxicological drug screening using 
LC-MS is given by Maurer [30].  
A Q-Trap-LC-MS/MS is usually not suitable for a full-scan screening, but it is suitable 
for a multi target screening (MTS). With an MTS one can combine the MRM mode 
with a spectral method such as enhanced product ion scan (EPI). Using information 
dependent acquisition (IDA) with a survey scan in the MRM mode, the sample is 
analyzed for a given number of analytes. If an analyte is tested positive, the signal 
triggers the second experiment, which delivers an EPI spectrum of the corresponding 
analyte. Mueller et al. developed that kind of method for 301 drugs [31] and Dresen et 
al. improved the MTS in order to detect and identify 700 drugs simultaneously using 
scheduled MRM (sMRM) transitions [32]. The unambiguous identification, e.g. with 
EPI, is especially important in cases with substances, that have similar transitions in 
the MRM mode. Allen showed that O-desmethylvenlafaxine, the metabolite of the 
antidepressant venlafaxine, can cause false positive results for tramadol due to partly 
identical transitions [33].  
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1.1.4.2.1 Identification criteria  
In clinical and forensic toxicology widely accepted criteria for mass spectrometry-
based compound identification are still under discussion [5,34,35]. For the mass 
spectrometric identification of drug residues in foodstuffs, guidelines can be found in 
Commission Decision of 12 August 2002 of the European Communities [36]. This 
document describes criteria for mass spectrometric detection. When using for 
example selected ion monitoring (SIM) or MRM, a system of identification points (IP) 
is applied. A minimum of 3 IP are requested. One can achieve that with working with 
3 SIM, which give 1 IP each, or with 2 MRM, which accounts for 1.5 IP each. For an 
unambiguous identification the combination of MRM and EPI is a good approach [37] 
that has also been followed in the presented work. 
 
1.1.4.2.2 Method validation 
A forensic toxicologist must be able to rely on his analytical results for evaluation and 
interpretation. Therefore it is essential that his analytical procedures provide him with 
correct results. Method validation can guarantee that. The German Society of 
Toxicology and Forensic Chemistry (GTFCh) developed guidelines for method 
validation in forensic toxicology [38]. Detailed descriptions of validation experiments 
especially for LC-MS have also been published [39]. The first part of a validation 
includes experiments concerning selectivity, matrix effects, extraction recovery, 
process efficiency, processed sample stability and linearity. The second part consists 
of experiments to evaluate the accuracy and precision and freeze and thaw stability. 
Peters stated that dealing with matrix effects is one of the key issues in LC-MS/MS 
[5]. Matuszewski et al. described an experimental approach in which matrix effects; 
recovery and process efficiency can be determined simultaneously [40]. This approach 
has also been used in the presented work. 
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1.2 AIMS AND SCOPES 
Forensic toxicological analyses have different challenges, e.g. uncommon analytes, 
different matrices and new releases on the illicit drug market. LC-MS/MS analysis is a 
useful tool to tackle these problems [5,28]. For quantitative purposes a determination in 
the MRM mode is appropriate and an unambiguous identification can be achieved 
through EPI spectra. 
 
Therefore, the aims of the presented studies were: 
 
- Development and validation of a quantitative method for the determination of 
phosphodiesterase-5 inhibitors and two of their metabolites in blood plasma 
with an application to therapeutic drug monitoring (TDM) and forensic cases 
 
- Development and validation of a quantitative method for the determination of 
benzodiazepines and z-drugs in hair by using the MRM-EPI mode and 
application to driving ability assessments  
 
- Extension of the classical drug screen by developing a qualitative screening 
method for new psychoactive substances in hair and application to 
retrospective studies for assessment of prevalence 
- 9 -
  
2 PUBLICATIONS OF THE RESULTS 
The results of the studies were published in the following papers: 
 
2.1 DETECTION AND VALIDATED QUANTIFICATION OF THE 
PHOSPHODIESTERASE TYPE 5 INHIBITORS SILDENAFIL, VARDENAFIL, 
TADALAFIL AND TWO OF THEIR METABOLITES IN HUMAN BLOOD PLASMA BY 
LC-MS/MS – APPLICATION TO FORENSIC AND THERAPEUTIC MONITORING 
CASES [41] (DOI: 10.1097/FTD.0B013E31827318B8)
- 10 -
  
2.2 DETECTION AND VALIDATED QUANTIFICATION OF 21 BENZODIAZEPINES 
AND 3 “Z-DRUGS” IN HUMAN HAIR BY LC-MS/MS [42]  
(DOI:10.1016/J.FORSCIINT.2011.07.052) 
- 11 -
  
2.3 PREVALENCE OF NEW PSYCHOACTIVE SUBSTANCES: A RETROSPECTIVE 
STUDY IN HAIR [43] (DOI:10.1002/dta.1338)
- 12 -
  
3 CONCLUSIONS 
A fully validated method for the determination of three phosphodiesterase-5-inhibitors 
and two of their metabolites in blood plasma has been developed and has also been 
applied to forensic cases and in therapeutic drug monitoring. Patients with pulmonary 
arterial hypertension and sildenafil treatment were monitored. Not only the 
concentration of sildenafil (Revatio®) could be used for therapeutic drug monitoring; 
the concentration of norsildenafil, the main metabolite, was monitored too.  
For the determination of 21 benzodiazepines and 3 z-drugs in hair a method has 
been developed that was also fully validated according to international guidelines. 
After a two-step extraction procedure, an unambiguous identification and 
quantification was possible using the MRM-IDA-EPI mode. This method has been 
successfully applied to driving ability assessments and is now in routine use in the 
forensic hair laboratory and has been used in hundreds of cases.  
The drug market is changing constantly and therefore it is important to be up to date. 
The extension of the classic drug screen was used for a retrospective study, which 
was based on reanalyzing hair samples of 2009 and 2010 from driving ability 
assessment cases for new psychoactive substances. This retrospective study proved 
that these new drugs are actually in use and that their prevalence is high. In 37% of 
the cases such drugs were found. At least the most common ones should be 
included in screening procedures in clinical and forensic toxicology. Thus, LC-MS/MS 
has proven to be a useful tool for tackling particular problems in forensic toxicology.  
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4 SUMMARY 
The presented studies are dealing with analytical challenges in forensic toxicology 
and how the LC-MS/MS technology can be a useful tool for solving those analytical 
problems. Two quantitative methods have been developed and validated. First, a 
method for the determination of PDE5-inhibitors in blood plasma has been set up that 
could be used for forensic cases and in therapeutic drug monitoring for patients 
suffering from pulmonary arterial hypertension and sildenafil treatment. Second, a 
method was developed for quantification of 21 benzodiazepines and three z-drugs in 
hair and has been applied in hundreds of driving ability cases. For both methods the 
MRM-mode was used; in the second method the information dependent acquisition 
(IDA) was integrated using an EPI scan for an unambiguous identification. To deal 
with a changing drug market, an extension of the classic drug screen was developed 
and a retrospective study in hair of 2009’s and 2010’s driving ability cases could 
reveal the prevalence of new psychoactive substances and gave useful hints which 
drugs should be integrated in daily routine procedures.  
In the presented work, LC-MS/MS has successfully been used for tackling particular 
problems in forensic toxicology. Validated quantification of different classes of drugs 
in blood as well as in hair and even screening for new psychoactive substances in 
hair were possible employing this versatile technique emphasizing the role of LC-MS 
in forensic toxicology. 
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6 ABBREVIATIONS 
4-MMC  Mephedrone (4-Methylmethcathione) 
BZP   Benzylpiperazine 
cGMP   Cyclic guanosine monophosphate 
DUID   Driving under the influence of drugs 
EPI   Enhanced product ion (scan) 
ESI   Electrospray ionization  
EtG   Ethyl glucuronide 
GC   Gas chromatography 
GTFCh  Gesellschaft für Toxikologie und Forensische Chemie 
IA   Immunoassay 
IDA   Information dependent acquisition 
IP   Identification point  
LC   Liquid chromatography 
LC-MS/MS  Liquid chromatography tandem mass spectrometry 
LLE   Liquid liquid extraction 
mCPP  meta-Chlorophenylpiperazine 
MDMA  Methylenedioxymethylamphetamine 
MDPV  Methylenedioxypyrovalerone 
MRM   Multi reaction monitoring 
MS   Mass spectrometry 
MTS   Multi target screening 
PDE5   Phosphodiesterase type 5 
SIL   Stable isotope labeled 
SIM   Selected ion monitoring 
sMRM  Scheduled multi reaction monitoring 
SoHT   Society of Hair Testing 
SPE   Solid phase extraction 
TDM   Therapeutic drug monitoring 
TFMPP  Trifluoromethylphenylpiperazine 
z-drugs  zolpidem, zopiclone, zaleplon 
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7 ZUSAMMENFASSUNG 
Im Rahmen dieser Dissertation wurde anhand von Studien gezeigt, dass die LC-
MS(/MS) Technologie ein nützliches Werkzeug für die Bearbeitung der analytischen 
Herausforderungen in der forensischen Toxikologie ist. Zuerst wurde eine Methode 
zur Bestimmung von PDE5-Hemmern im Blutplasma aufgesetzt, die in forensischen 
Fällen und im Therapeutischen Drug Monitoring Anwendung fand. Als zweites konnte 
eine Methode zur Bestimmung von 21 Benzodiazepinen und den Z-Hypnotika in 
Haaren entwickelt werden, die in Fahreignungsbegutachtungs-Fällen eingesetzt 
wurde. Für beide Methoden wurde der MRM-Modus benutzt; die zweite Methode 
wurde durch die „Information Dependent Acquisition“ und den EPI-Scan für eine 
gesicherte Identifizierung erweitert. Das klassische Drogenscreening wurde um neue 
psychoaktive Substanzen erweitert. Eine retrospektive Studie in Haaren von 
Fahreignungs-Fällen aus 2009 und 2010, konnte die hohe Prävalenz dieser 
Substanzen aufzeigen und Hinweise geben, welche Substanzen in die Routine zu 
integrieren sind. 
In der vorliegenden Arbeit wurde die LC-MS/MS Technik erfolgreich eingesetzt, um 
einige der speziellen Fragestellungen der forensischen Toxikologie zu beantworten. 
Mit dieser Technik konnten sowohl validierte quantitative Bestimmungen 
verschiedener Analyten in Blut und Haaren als auch eine gerichtete Suchanalyse auf 
neue psychoaktive Substanzen in Haaren verwirklicht werden, was die wichtige Rolle 
dieser vielseitigen Technik für die forensische Toxikologie unterstreicht.  
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